Skip to main content
. 2005 Jan;49(1):241–248. doi: 10.1128/AAC.49.1.241-248.2005

TABLE 3.

Growth promotion of Candida species by different hydroxamate siderophores and susceptibility to siderophore-drug conjugates

Siderophore preference and strain Growtha of Candida species on:
MICb (μM) in iron-rich medium/iron-low medium (ratio) of compound:
FCH FOB ORNI ISO RHO DE DE-mono DE-tri DE-iso
Most hydroxamates
    Calb1 ++++ +++ 0.8/0.2 (4) 50/3.1 (16) 25/12.5 (2) 200/25 (8)
    Calb2 ++++ +++ + 0.8/0.4 (2) 6.25/1.6 (4) 25/12.5 (2) 200/50 (4)
    C. pseudotropicalis ++++ +++ 1.6/1.6 (1) 12.5/6.25 (2) 50/25 (2) 200/25 (8)
    C. stellatoidea + ++ 0.8/0.4 (2) 12.5/6.25 (2) 50/25 (2) 200/50 (4)
Isocyanurate-based hydroxamate
    C. krusei ++ 0.2/0.2 (1) 3.1/3.1 (1) 25/25 (1) >200/100 (≥4)
    C. parapsilosis ++ 0.2/0.1 (2) 1.6/1.6 (1) 12.5/12.5 (1) 100/50 (2)
    C. guilliermondii + + 6.25/3.1 (2) 25/25 (1) 50/50 (1) >200/200 (≥2)
a

Relative growth in the presence of siderophore (25 μM for ferrichrome [FCH], ferrioxamine B [FOB], and omithine-based trihydroxamate [ORNI] or 200 μM for isocyanurate-based hydroxamate [ISO] and rhodotorulic acid [RHO]) in YPD broth supplemented with 2,2′-dipyridyl compared to growth in YPD broth. −, 0 to 20%; +, 21 to 40%; ++, 41 to 60%; +++, 61 to 80%; ++++, 81 to 100%.

b

MIC determined in YPD broth (iron-rich medium, first value) and in YPD broth supplemented with 0.15 mM 2,2′-dipyridyl or 0.20 mM for C. pseudotropicalis (iron-low medium, second value).